An Integrative Pan-Cancer Analysis of the Oncogenic Role of COPB2 in Human Tumors

Several studies have suggested that coatomer protein complex subunit beta 2 (COPB2) may act as an oncogene in various cancer types. However, no systematic pan-cancer analysis has been performed to date. Therefore, the present study analyzed the potential oncogenic role of COPB2 using TCGA (The Cance...

Full description

Saved in:
Bibliographic Details
Published in:BioMed research international 2021, Vol.2021 (1), p.7405322-7405322
Main Authors: Wu, Biao, Wu, Yumeng, Guo, Xianlin, Yue, Yanping, Li, Yuanyuan, He, Xiao, Chen, Yuanbin, Zhao, Wenjing, Liu, Jibin, Wu, Xuming, Shen, Aiguo, Zhang, Suqing
Format: Article
Language:English
Subjects:
Analysis
Binding proteins
Biomedical research
Breast
Cancer
Carcinogenesis
Cervix
Chemotherapy
Coatomer Protein - genetics
Coatomer Protein - metabolism
Colon
Computational Biology
Databases, Genetic
Datasets
Diagnosis
Endometrial cancer
Endometrium
Fibroblasts
Gene expression
Genetic aspects
Genomes
Health aspects
Humans
Identification and classification
Molecular Targeted Therapy - methods
Mutation
Neoplasms - genetics
Neoplasms - metabolism
Neoplasms - pathology
Oncogenes
Ovarian cancer
Physiological aspects
Prognosis
Proteins
Survival Rate
Transforming growth factors
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c504t-3656ca073099cd1612885263ad170be1eb79ce0a0a7c5817015a7ae278c276693
cites cdi_FETCH-LOGICAL-c504t-3656ca073099cd1612885263ad170be1eb79ce0a0a7c5817015a7ae278c276693
container_end_page 7405322
container_issue 1
container_start_page 7405322
container_title BioMed research international
container_volume 2021
creator Wu, Biao
Wu, Yumeng
Guo, Xianlin
Yue, Yanping
Li, Yuanyuan
He, Xiao
Chen, Yuanbin
Zhao, Wenjing
Liu, Jibin
Wu, Xuming
Shen, Aiguo
Zhang, Suqing
description Several studies have suggested that coatomer protein complex subunit beta 2 (COPB2) may act as an oncogene in various cancer types. However, no systematic pan-cancer analysis has been performed to date. Therefore, the present study analyzed the potential oncogenic role of COPB2 using TCGA (The Cancer Genome Atlas) and GEO (Gene Expression Omnibus) datasets. The majority of the cancer types overexpressed the COPB2 protein, and its expression significantly correlated with tumor prognosis. In certain tumors, such as those found in breast and ovarian tissues, phosphorylated S859 exhibited high expression. It was found that mutations of the COPB2 protein in kidney and endometrial cancers exhibited a significant impact on patient prognosis. It is interesting to note that COPB2 expression correlated with the number of cancer-associated fibroblasts in certain tumors, such as cervical and endocervical cancers and colon adenocarcinomas. In addition, COPB2 was involved in the transport of substances and correlated with chemotherapy sensitivity. This is considered the first pan-tumor study, which provided a relatively comprehensive understanding of the mechanism by which COPB2 promotes cancer growth.
doi_str_mv 10.1155/2021/7405322
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8526247</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A696844322</galeid><sourcerecordid>A696844322</sourcerecordid><originalsourceid>FETCH-LOGICAL-c504t-3656ca073099cd1612885263ad170be1eb79ce0a0a7c5817015a7ae278c276693</originalsourceid><addsrcrecordid>eNqFkU1vEzEQhi0EolXpjTOyxAUJlvrbuxekNAJaqVIKKmdr4kwSV7t2sXeL-u_ZJSF8HMAXW-NHz2jmJeQ5Z2851_pMMMHPrGJaCvGIHAvJVWW44o8PbymPyGkpt2w8NTesMU_JkVTGGmHEMfk0i_Qy9rjJ0Id7pNcQqzlEj5nOIrQPJRSa1rTfIl1EnzYYg6efU4tTdb64Phc0RHoxdBDpzdClXJ6RJ2toC57u7xPy5cP7m_lFdbX4eDmfXVVeM9VX0mjjgVnJmsavuOGirrUwElbcsiVyXNrGIwMG1ut6rHENFlDY2gtrTCNPyLud925YdrjyGPsMrbvLoYP84BIE9-dPDFu3SfduaiOUHQWv9oKcvg5YeteF4rFtIWIaihO6VkraRpkRffkXepuGPO7nB6V5UxsmflEbaNGFuE5jXz9J3cw0ZrKJ_1C11FoozUfqzY7yOZWScX0YjDM3Re-m6N0--hF_8fsyDvDPoEfg9Q7YhriCb-Hfuu9Xk7BH</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2585198602</pqid></control><display><type>article</type><title>An Integrative Pan-Cancer Analysis of the Oncogenic Role of COPB2 in Human Tumors</title><source>Publicly Available Content Database</source><source>Wiley Open Access Journals</source><creator>Wu, Biao ; Wu, Yumeng ; Guo, Xianlin ; Yue, Yanping ; Li, Yuanyuan ; He, Xiao ; Chen, Yuanbin ; Zhao, Wenjing ; Liu, Jibin ; Wu, Xuming ; Shen, Aiguo ; Zhang, Suqing</creator><contributor>Ma, Yong Xin ; Yong Xin Ma</contributor><creatorcontrib>Wu, Biao ; Wu, Yumeng ; Guo, Xianlin ; Yue, Yanping ; Li, Yuanyuan ; He, Xiao ; Chen, Yuanbin ; Zhao, Wenjing ; Liu, Jibin ; Wu, Xuming ; Shen, Aiguo ; Zhang, Suqing ; Ma, Yong Xin ; Yong Xin Ma</creatorcontrib><description>Several studies have suggested that coatomer protein complex subunit beta 2 (COPB2) may act as an oncogene in various cancer types. However, no systematic pan-cancer analysis has been performed to date. Therefore, the present study analyzed the potential oncogenic role of COPB2 using TCGA (The Cancer Genome Atlas) and GEO (Gene Expression Omnibus) datasets. The majority of the cancer types overexpressed the COPB2 protein, and its expression significantly correlated with tumor prognosis. In certain tumors, such as those found in breast and ovarian tissues, phosphorylated S859 exhibited high expression. It was found that mutations of the COPB2 protein in kidney and endometrial cancers exhibited a significant impact on patient prognosis. It is interesting to note that COPB2 expression correlated with the number of cancer-associated fibroblasts in certain tumors, such as cervical and endocervical cancers and colon adenocarcinomas. In addition, COPB2 was involved in the transport of substances and correlated with chemotherapy sensitivity. This is considered the first pan-tumor study, which provided a relatively comprehensive understanding of the mechanism by which COPB2 promotes cancer growth.</description><identifier>ISSN: 2314-6133</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2021/7405322</identifier><identifier>PMID: 34676262</identifier><language>eng</language><publisher>United States: Hindawi</publisher><subject>Analysis ; Binding proteins ; Biomedical research ; Breast ; Cancer ; Carcinogenesis ; Cervix ; Chemotherapy ; Coatomer Protein - genetics ; Coatomer Protein - metabolism ; Colon ; Computational Biology ; Databases, Genetic ; Datasets ; Diagnosis ; Endometrial cancer ; Endometrium ; Fibroblasts ; Gene expression ; Genetic aspects ; Genomes ; Health aspects ; Humans ; Identification and classification ; Molecular Targeted Therapy - methods ; Mutation ; Neoplasms - genetics ; Neoplasms - metabolism ; Neoplasms - pathology ; Oncogenes ; Ovarian cancer ; Physiological aspects ; Prognosis ; Proteins ; Survival Rate ; Transforming growth factors ; Tumors</subject><ispartof>BioMed research international, 2021, Vol.2021 (1), p.7405322-7405322</ispartof><rights>Copyright © 2021 Biao Wu et al.</rights><rights>COPYRIGHT 2021 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2021 Biao Wu et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2021 Biao Wu et al. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c504t-3656ca073099cd1612885263ad170be1eb79ce0a0a7c5817015a7ae278c276693</citedby><cites>FETCH-LOGICAL-c504t-3656ca073099cd1612885263ad170be1eb79ce0a0a7c5817015a7ae278c276693</cites><orcidid>0000-0001-8475-4747 ; 0000-0003-0182-9454 ; 0000-0001-7648-365X ; 0000-0003-1821-9759</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2585198602/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2585198602?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,4021,25751,27921,27922,27923,37010,37011,44588,74896</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34676262$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Ma, Yong Xin</contributor><contributor>Yong Xin Ma</contributor><creatorcontrib>Wu, Biao</creatorcontrib><creatorcontrib>Wu, Yumeng</creatorcontrib><creatorcontrib>Guo, Xianlin</creatorcontrib><creatorcontrib>Yue, Yanping</creatorcontrib><creatorcontrib>Li, Yuanyuan</creatorcontrib><creatorcontrib>He, Xiao</creatorcontrib><creatorcontrib>Chen, Yuanbin</creatorcontrib><creatorcontrib>Zhao, Wenjing</creatorcontrib><creatorcontrib>Liu, Jibin</creatorcontrib><creatorcontrib>Wu, Xuming</creatorcontrib><creatorcontrib>Shen, Aiguo</creatorcontrib><creatorcontrib>Zhang, Suqing</creatorcontrib><title>An Integrative Pan-Cancer Analysis of the Oncogenic Role of COPB2 in Human Tumors</title><title>BioMed research international</title><addtitle>Biomed Res Int</addtitle><description>Several studies have suggested that coatomer protein complex subunit beta 2 (COPB2) may act as an oncogene in various cancer types. However, no systematic pan-cancer analysis has been performed to date. Therefore, the present study analyzed the potential oncogenic role of COPB2 using TCGA (The Cancer Genome Atlas) and GEO (Gene Expression Omnibus) datasets. The majority of the cancer types overexpressed the COPB2 protein, and its expression significantly correlated with tumor prognosis. In certain tumors, such as those found in breast and ovarian tissues, phosphorylated S859 exhibited high expression. It was found that mutations of the COPB2 protein in kidney and endometrial cancers exhibited a significant impact on patient prognosis. It is interesting to note that COPB2 expression correlated with the number of cancer-associated fibroblasts in certain tumors, such as cervical and endocervical cancers and colon adenocarcinomas. In addition, COPB2 was involved in the transport of substances and correlated with chemotherapy sensitivity. This is considered the first pan-tumor study, which provided a relatively comprehensive understanding of the mechanism by which COPB2 promotes cancer growth.</description><subject>Analysis</subject><subject>Binding proteins</subject><subject>Biomedical research</subject><subject>Breast</subject><subject>Cancer</subject><subject>Carcinogenesis</subject><subject>Cervix</subject><subject>Chemotherapy</subject><subject>Coatomer Protein - genetics</subject><subject>Coatomer Protein - metabolism</subject><subject>Colon</subject><subject>Computational Biology</subject><subject>Databases, Genetic</subject><subject>Datasets</subject><subject>Diagnosis</subject><subject>Endometrial cancer</subject><subject>Endometrium</subject><subject>Fibroblasts</subject><subject>Gene expression</subject><subject>Genetic aspects</subject><subject>Genomes</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Identification and classification</subject><subject>Molecular Targeted Therapy - methods</subject><subject>Mutation</subject><subject>Neoplasms - genetics</subject><subject>Neoplasms - metabolism</subject><subject>Neoplasms - pathology</subject><subject>Oncogenes</subject><subject>Ovarian cancer</subject><subject>Physiological aspects</subject><subject>Prognosis</subject><subject>Proteins</subject><subject>Survival Rate</subject><subject>Transforming growth factors</subject><subject>Tumors</subject><issn>2314-6133</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqFkU1vEzEQhi0EolXpjTOyxAUJlvrbuxekNAJaqVIKKmdr4kwSV7t2sXeL-u_ZJSF8HMAXW-NHz2jmJeQ5Z2851_pMMMHPrGJaCvGIHAvJVWW44o8PbymPyGkpt2w8NTesMU_JkVTGGmHEMfk0i_Qy9rjJ0Id7pNcQqzlEj5nOIrQPJRSa1rTfIl1EnzYYg6efU4tTdb64Phc0RHoxdBDpzdClXJ6RJ2toC57u7xPy5cP7m_lFdbX4eDmfXVVeM9VX0mjjgVnJmsavuOGirrUwElbcsiVyXNrGIwMG1ut6rHENFlDY2gtrTCNPyLud925YdrjyGPsMrbvLoYP84BIE9-dPDFu3SfduaiOUHQWv9oKcvg5YeteF4rFtIWIaihO6VkraRpkRffkXepuGPO7nB6V5UxsmflEbaNGFuE5jXz9J3cw0ZrKJ_1C11FoozUfqzY7yOZWScX0YjDM3Re-m6N0--hF_8fsyDvDPoEfg9Q7YhriCb-Hfuu9Xk7BH</recordid><startdate>2021</startdate><enddate>2021</enddate><creator>Wu, Biao</creator><creator>Wu, Yumeng</creator><creator>Guo, Xianlin</creator><creator>Yue, Yanping</creator><creator>Li, Yuanyuan</creator><creator>He, Xiao</creator><creator>Chen, Yuanbin</creator><creator>Zhao, Wenjing</creator><creator>Liu, Jibin</creator><creator>Wu, Xuming</creator><creator>Shen, Aiguo</creator><creator>Zhang, Suqing</creator><general>Hindawi</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-8475-4747</orcidid><orcidid>https://orcid.org/0000-0003-0182-9454</orcidid><orcidid>https://orcid.org/0000-0001-7648-365X</orcidid><orcidid>https://orcid.org/0000-0003-1821-9759</orcidid></search><sort><creationdate>2021</creationdate><title>An Integrative Pan-Cancer Analysis of the Oncogenic Role of COPB2 in Human Tumors</title><author>Wu, Biao ; Wu, Yumeng ; Guo, Xianlin ; Yue, Yanping ; Li, Yuanyuan ; He, Xiao ; Chen, Yuanbin ; Zhao, Wenjing ; Liu, Jibin ; Wu, Xuming ; Shen, Aiguo ; Zhang, Suqing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c504t-3656ca073099cd1612885263ad170be1eb79ce0a0a7c5817015a7ae278c276693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Analysis</topic><topic>Binding proteins</topic><topic>Biomedical research</topic><topic>Breast</topic><topic>Cancer</topic><topic>Carcinogenesis</topic><topic>Cervix</topic><topic>Chemotherapy</topic><topic>Coatomer Protein - genetics</topic><topic>Coatomer Protein - metabolism</topic><topic>Colon</topic><topic>Computational Biology</topic><topic>Databases, Genetic</topic><topic>Datasets</topic><topic>Diagnosis</topic><topic>Endometrial cancer</topic><topic>Endometrium</topic><topic>Fibroblasts</topic><topic>Gene expression</topic><topic>Genetic aspects</topic><topic>Genomes</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Identification and classification</topic><topic>Molecular Targeted Therapy - methods</topic><topic>Mutation</topic><topic>Neoplasms - genetics</topic><topic>Neoplasms - metabolism</topic><topic>Neoplasms - pathology</topic><topic>Oncogenes</topic><topic>Ovarian cancer</topic><topic>Physiological aspects</topic><topic>Prognosis</topic><topic>Proteins</topic><topic>Survival Rate</topic><topic>Transforming growth factors</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wu, Biao</creatorcontrib><creatorcontrib>Wu, Yumeng</creatorcontrib><creatorcontrib>Guo, Xianlin</creatorcontrib><creatorcontrib>Yue, Yanping</creatorcontrib><creatorcontrib>Li, Yuanyuan</creatorcontrib><creatorcontrib>He, Xiao</creatorcontrib><creatorcontrib>Chen, Yuanbin</creatorcontrib><creatorcontrib>Zhao, Wenjing</creatorcontrib><creatorcontrib>Liu, Jibin</creatorcontrib><creatorcontrib>Wu, Xuming</creatorcontrib><creatorcontrib>Shen, Aiguo</creatorcontrib><creatorcontrib>Zhang, Suqing</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Database‎ (1962 - current)</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wu, Biao</au><au>Wu, Yumeng</au><au>Guo, Xianlin</au><au>Yue, Yanping</au><au>Li, Yuanyuan</au><au>He, Xiao</au><au>Chen, Yuanbin</au><au>Zhao, Wenjing</au><au>Liu, Jibin</au><au>Wu, Xuming</au><au>Shen, Aiguo</au><au>Zhang, Suqing</au><au>Ma, Yong Xin</au><au>Yong Xin Ma</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An Integrative Pan-Cancer Analysis of the Oncogenic Role of COPB2 in Human Tumors</atitle><jtitle>BioMed research international</jtitle><addtitle>Biomed Res Int</addtitle><date>2021</date><risdate>2021</risdate><volume>2021</volume><issue>1</issue><spage>7405322</spage><epage>7405322</epage><pages>7405322-7405322</pages><issn>2314-6133</issn><eissn>2314-6141</eissn><abstract>Several studies have suggested that coatomer protein complex subunit beta 2 (COPB2) may act as an oncogene in various cancer types. However, no systematic pan-cancer analysis has been performed to date. Therefore, the present study analyzed the potential oncogenic role of COPB2 using TCGA (The Cancer Genome Atlas) and GEO (Gene Expression Omnibus) datasets. The majority of the cancer types overexpressed the COPB2 protein, and its expression significantly correlated with tumor prognosis. In certain tumors, such as those found in breast and ovarian tissues, phosphorylated S859 exhibited high expression. It was found that mutations of the COPB2 protein in kidney and endometrial cancers exhibited a significant impact on patient prognosis. It is interesting to note that COPB2 expression correlated with the number of cancer-associated fibroblasts in certain tumors, such as cervical and endocervical cancers and colon adenocarcinomas. In addition, COPB2 was involved in the transport of substances and correlated with chemotherapy sensitivity. This is considered the first pan-tumor study, which provided a relatively comprehensive understanding of the mechanism by which COPB2 promotes cancer growth.</abstract><cop>United States</cop><pub>Hindawi</pub><pmid>34676262</pmid><doi>10.1155/2021/7405322</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-8475-4747</orcidid><orcidid>https://orcid.org/0000-0003-0182-9454</orcidid><orcidid>https://orcid.org/0000-0001-7648-365X</orcidid><orcidid>https://orcid.org/0000-0003-1821-9759</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2314-6133
ispartof BioMed research international, 2021, Vol.2021 (1), p.7405322-7405322
issn 2314-6133
2314-6141
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8526247
source Publicly Available Content Database; Wiley Open Access Journals
subjects Analysis
Binding proteins
Biomedical research
Breast
Cancer
Carcinogenesis
Cervix
Chemotherapy
Coatomer Protein - genetics
Coatomer Protein - metabolism
Colon
Computational Biology
Databases, Genetic
Datasets
Diagnosis
Endometrial cancer
Endometrium
Fibroblasts
Gene expression
Genetic aspects
Genomes
Health aspects
Humans
Identification and classification
Molecular Targeted Therapy - methods
Mutation
Neoplasms - genetics
Neoplasms - metabolism
Neoplasms - pathology
Oncogenes
Ovarian cancer
Physiological aspects
Prognosis
Proteins
Survival Rate
Transforming growth factors
Tumors
title An Integrative Pan-Cancer Analysis of the Oncogenic Role of COPB2 in Human Tumors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T15%3A07%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20Integrative%20Pan-Cancer%20Analysis%20of%20the%20Oncogenic%20Role%20of%20COPB2%20in%20Human%20Tumors&rft.jtitle=BioMed%20research%20international&rft.au=Wu,%20Biao&rft.date=2021&rft.volume=2021&rft.issue=1&rft.spage=7405322&rft.epage=7405322&rft.pages=7405322-7405322&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2021/7405322&rft_dat=%3Cgale_pubme%3EA696844322%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c504t-3656ca073099cd1612885263ad170be1eb79ce0a0a7c5817015a7ae278c276693%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2585198602&rft_id=info:pmid/34676262&rft_galeid=A696844322&rfr_iscdi=true